This method was pioneered at the National Cancer Institute in the 1980s, and recently resulted in durable remission of metastatic HR breast cancer in a patient treated with autologous TILs enriched for T cells reactive against autologous neoantigens and administered following lymphodepleting chemotherapy and in combination with pembrolizumab https://zithromax.top>z pack for strep